Increased incidence of neutralizing autoantibodies against interleukin-1α (IL-1α) in nondestructive chronic polyarthritis

Journal of Clinical Immunology

Volumn 16, Issue 5, 1996, Pages 283-290

  Jouvenne, Patricia ^a   Fossiez, François ^b   Garrone, Pierre ^b   Djossou, Odile ^b   Banchereau, Jacques ^b   Miossec, Pierre ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

autoantibodies; cytokines; interleukin 1; rheumatoid arthritis

Indexed keywords

AUTOANTIBODY; HLA DR ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA;

ADULT; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS; AUTOANTIBODIES; BINDING, COMPETITIVE; FEMALE; HLA-DR4 ANTIGEN; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-1; MALE; MIDDLE AGED; NECROSIS;

EID: 0029793315     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01541394     Document Type: Article

References (24)

1. Brennan FM, Maini RN, Feldmann M: TNF alpha: A pivotal role in rheumatoid arthritis? Br J Rheumatol 31:293-298, 1992
2. Miossec P: Cytokine abnormalities in inflammatory arthritis. In New Developments in Investigation and Management of Early Inflammatory Arthritis, P Emery (ed). London, Ballière Tindall, 1992, pp 373-392
3. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110, 1994
4. Arend WP, Dayer JM: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arth Rheum 38:151-160, 1995
5. Dinarello CA: The interleukin-1 family: 10 years of discovery. FASEB J 8:1314-1325, 1994
6. Bendtzen K, Svenson M, Jonsson V, Hippe E: Autoantibodies to cytokines: Friends or foes? Immunol Today 11:167-169, 1990
7. Svenson M, Poulsen LK. Fomsgaard A, Bendtzen K: IgG autoantibodies against interleukin 1α in sera of normal individuals. Scand J Immunol 29:489-492, 1989
8. Gallay P, Mach J-P, Carrel S: Characterization and detection of naturally occurring antibodies against IL-1α and IL-1β in normal human plasma. Eur Cytokine Netw 2:329-338, 1991
9. Hansen MB, Svenson M, Bendtzen K: Human anti-interleukin 1α antibodies. Immunol Lett 30:133-140, 1991
10. Saurat JH, Schifferli J, Steiger G, Dayer JM, Didierjean L: Anti-interleukin-1α autoantibodies in humans: Characterization, isotype distribution, and receptor-binding inhibition. Higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol 88:244-256, 1991
11. Svenson M, Hansen MB, Bendtzen K: Binding of cytokines to pharmaceutically prepared human immunoglobulin, J Clin Invest 92:2533-2539, 1993
12. Suzuki H, Akama T, Okane M, Kono I, Matsui Y, Yamane K, Kashiwagi H: Interleukin-1-inhibitory IgG in sera from some patients with rheumatoid arthritis. Arth Rheum 32:1528-1538, 1989
13. Suzuki H, Kamimura J, Ayabe T, Kashiwagi H: Demonstration of neutralizing autoantibodies against IL-1α in sera from patients with rheumatoid arthritis. J Immunol 145:2140-2146, 1990
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Pries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Nenstadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GC: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arth Rheum 31:315-324, 1988
15. Greenspan JS, Daniels TE, Talal N, Sylvester RA: The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg 37:217-229, 1974
16. Tunn EJ, Bacon PA: Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheum 32:97-103, 1993
17. Grassi J, Roberge CJ, Frobert Y, PP, Poubelle PE: Determination of IL1 α, IL1 β in biological media using specific enzyme immunometric assays. Immunol Rev 119:125-145, 1991
18. Beuscher HU, Rausch U-P, Otterness IG, Röllinghoff M: Transition from Interleukin 1β (IL-1β) to IL-1α production during maturation of inflammatory macrophages in vivo. J Exp Med 175:1793-1797, 1992
19. Deleuran BW, Chu CQ, Field M, Brennan FM, Katsikis P, Feldmann M, Maini RN: Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 31:801-809, 1992
20. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN: Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: Implications for the role of cytokines in cartilage destruction and repair. Br J Rheum 31:653-661, 1992
21. Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M: Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clin Exp Immunol 73:449-455, 1988
22. Van de Loo AAJ, Arntz OJ, Bakker AC, Van Lent PLEM, Jacobs MJM, Van den Berg WB: Role of interleukin 1 in antigen-induced exacerbations of murine arthritis. Am J Pathol 146:239-249. 1995
23. Garonne P, Djossou O, Fossiez F, Reyes J, Ait-Yahia S, Maat C, Ho S, Hauser T, Dayer JM, Miossec P, Lebeque S, Rousset F, Banchereau J: Generation of a human monoclonal autoantibody that acts as a high affinity IL-1α specific inhibitor. Mol Immunol 33:649-658, 1996
24. Williams RO, Mason LJ, Feldmann M, Maini RM: Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci USA 91:2762-2766, 1994